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Summary
Vampire bat rabies causes significant impacts within its endemic range in Mexico.
These impacts include livestock mortality, animal testing costs, post-exposure
prophylaxis costs, and human mortality risk. Mitigation of the impacts can be
achieved by vaccinating livestock and controlling vampire bat populations. A ben-
efit-cost analysis was performed to examine the economic efficiency of these
methods of mitigation, and Monte Carlo simulations were used to examine the
impact that uncertainty has on the analysis. We found that livestock vaccination
is efficient, with benefits being over six times higher than costs. However, bat
control is inefficient because benefits are very unlikely to exceed costs. It is con-
cluded that when these mitigation methods are judged by the metric of economic
efficiency, livestock vaccination is desirable but bat control is not.
Introduction
A conventional technique used to manage rabies in wildlife
is oral rabies vaccination (ORV). Baits containing the vac-
cine are distributed into rabies endemic regions and inocu-
lation occurs after the baits are consumed by the vector
species (Sterner et al., 2009), and successful elimination of
the domestic dog-coyote variant rabies from the United
States was achieved in 2008 using this technique (Shwiff
et al., 2008). Management of rabies in bat populations
poses a management problem because vaccination of bat
populations through ORV campaigns is not possible given
current technology.
Rabies transmitted by the common vampire bat (Desmo-
dus rotundus) is a major public health concern in subtropical
and tropical areas of Latin America (World Health Organi-
zation, 2005). Infected vampire bats can transmit rabies to
domestic mammals and humans through their haematopha-
gous behaviour (Turner, 1975). In this region of the world,
although transmission of rabies from bats to humans is more
common than transmission by feral dogs (Schneider et al.,
2005), vampire bats are the species most often responsible
for the spread rabies to livestock (Acha and Málaga Alba,
1988; World Health Organization, 2005, 2007).
In Mexico, the common vampire bat is widely distrib-
uted and abundant in local concentrations (Lord et al.,
1988). The expansion of villages and livestock range and
the subsequent manufacturing of wells, buildings, tunnels
and mines have opened areas as roosts that were previously
unavailable, resulting in an increase in the transmission of
rabies to livestock and humans (Flores-Crespo and Arellan-
o-Sota, 1991). When rabies is transmitted to livestock or
humans, in the absence of timely treatment, death occurs.
The mortality risk to humans also leads to relatively high
rates of post-exposure prophylaxis (PEP) use. Even when
rabies is not transmitted, harm to livestock production
from vampire bat feeding behaviour can be significant and
includes damaged hides, weight loss and decreased milk
production. All of these impacts have economic conse-
quences for livestock producers, governments and local
communities in the vampire bat rabies endemic region of
Mexico (Acha and Málaga Alba, 1988).
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Because eradication of rabies in bats is currently impossible,
mitigation techniques to reduce damage caused by vampire
bat transmitted rabies must be implemented. These tech-
niques include pre-exposure vaccination of cattle and targeted
management of vampire bat populations (World Health
Organization, 2005). When administered correctly, pre-expo-
sure vaccination significantly reduces rabies-caused cattle
mortality. Vampire bat control management programs consist
of field application of anticoagulants to the target species,
resulting in multiple deaths because of colony grooming hab-
its (Linhart, 1972). In Mexico, these techniques are currently
implemented in a limited manner, with few cattle being
vaccinated and bat control conducted only in select areas.
Numerous economic studies have characterized rabies-
related impacts including the estimation of direct and indi-
rect costs associated with wildlife rabies and benefit-cost
analyses of ORV programs (Shwiff et al., 2007). In many of
these studies, a major justification for the vaccination and/
or animal control programs focused upon historic and esti-
mated future frequencies and expenditures on PEP and
animal rabies tests (AT). In Mexico, however, livestock
losses comprise the majority of the economic costs associ-
ated with vampire bat transmitted rabies (Arámbulo and
Thakur, 1992).
In this study, a benefit-cost analysis was conducted to
evaluate the economic efficiency of a vampire bat rabies
management program implemented in the entire vampire
bat rabies endemic region in Mexico. The management
program that was considered consisted of vampire bat
population control and cattle pre-exposure vaccination.
Economic efficiency was evaluated from both private and
social perspectives, and Monte Carlo simulations were used
to account for uncertainty inherent in the analysis.
Materials and Methods
A policy or action is judged economically efficient if the
benefits produced outweigh the costs incurred, and ineffi-
ciency is implied when the value of resources used to pro-
duce some benefit outweigh that benefit. In this analysis, it
is appropriate to judge efficiency from two standpoints:
private and social. The proposed rabies management pro-
gram consists of both a bat control component and a cattle
vaccination component. If cattle producers incur the costs
of vaccination, it is valuable to calculate the net benefit of
these vaccinations where the benefit is reduced livestock
mortality and the resulting increase in revenue. This allows
efficiency to be judged from a private (the cattle produc-
ers’) perspective. However, the vaccination program will
also reduce the need for rabies testing, a benefit that does
not accrue to the cattle producers. Additionally, the vacci-
nation program may be subsidized. It is therefore desirable
to also evaluate the program from a social standpoint,
which accounts for all benefits and costs, regardless of their
distribution. The bat control program is evaluated from a
purely social perspective because the costs accrue to taxpay-
ers while the benefits accrue to a combination of private
individuals and the healthcare sector.
Efficiency can be measured in two ways: net benefits and
benefit-cost ratios. While these may seem to provide equiv-
alent information, there is a subtle difference. The net bene-
fit and benefit-cost ratios calculated in this analysis assume
the management program is fully implemented. In practice,
it is possible that neither component of the management
program is fully implemented. In such a case, the net bene-
fit of the full program may not be directly applicable, but
the benefit-cost ratios still provide useful information.
Regardless of the scale of implementation, the benefit-cost
ratios can be interpreted as the value of benefits provided
by every Peso spent. This contrasts with the calculated net
benefit, which is only applicable when the scale of actual
implementation matches the scale of implementation for
which the net benefit was calculated.
Calculation of the appropriate benefit-cost ratios and net
benefits require estimates of each of the variables appearing
in Table 1. While the full list of estimates for each of these
appears in Table 3, an overview of how each was estimated
is warranted given their importance in the analysis.
Twenty-four states in Mexico had cattle test positive for
vampire bat rabies at least once between 1997 and 2006.
These states, henceforth referred to as the rabies endemic
region, were Campeche, Chiapas, Chihuahua, Colima,
Durango, Guerrero, Hidalgo, Jalisco, Mexico, Michoacán,
Morelos, Nayarit, Oaxaca, Puebla, Queretaro, Quintana
Roo, San Luis Potosı́, Sinaloa, Sonora, Tabasco, Tamauli-
pas, Veracruz, Yucatan and Zacatecas. Within the region
these states make up, in 2003, there were 13.7 million
susceptible cattle with a market value of approximately
Mex$6840 each (SIAP, 2007).
Table 1. Variable definitions
Description Variable Description Variable
Cattle population N Cattle price Pn
Mortality rate M Vaccine effectiveness V
Unit cost of vaccine Pv Unit cost of PEP Ppep
Quantity of vaccine Qv Quantity of PEP Qpep
Unit cost of coolers Pc Unit of cost of animal
tests
Pat
Quantity of coolers Qc Quantity of animal tests Qat
Unit cost of ice Pi Bat control program cost B
Quantity of ice Qi % of PEP avoided by bat
control program
PEP
Unit cost of fuel Pf % of AT avoided by
vaccine program
AT
Quantity of fuel Qf Cattle price Pn
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During the 10-year period between 1997 and 2006, 2769
cattle sent from the endemic region to a national laboratory
tested positive for rabies (SAGARPA, 2007). Numerous
studies have reported that this is a substantial underesti-
mate of the actual number of cattle who contracted and
subsequently died from vampire bat transmitted rabies
(Prieto and Baer, 1972; Baer, 1991; World Health Organiza-
tion, 2005). Conservatively, the official mortality rate as
reported by the Secretarı́a de Agricultura, Ganaderı́a, De-
sarrollo Rural, Pesca y Alimentación (SAGARPA) was more
than double the mortality rate indicated by the number of
animals that tested positive in a laboratory. Published esti-
mates of cattle mortality owing to vampire bat rabies expo-
sure estimated that between 90 000 and 100 000 head of
cattle died each year in Mexico (approximately 1% mortal-
ity rate) (Acha, 1967). Additional reports related to specific
study sites or recent epizootics estimated that the mortality
rate ranges from 4% to >20% (Prieto and Baer, 1972; Baer,
1991; Martı́nez-Burnes et al., 1997). Given the wide range
of published estimates for the purposes of this study, an
estimate of 1% for cattle mortality will be used as a starting
point.
Between 1997 and 2006, the average annual number of
PEPs in Mexico was 955 at a cost of Mex$1500 per patient,
and the number of AT were 283 at a cost of Mex$120 per
test (SAGARPA, 2007). Owing to the uncertainty associated
with the effectiveness of the rabies management programs,
we estimated a plausible range of management program
effectiveness where effectiveness is measured as percent
reduction in cattle mortality owing to vaccination and per-
cent reduction in PEPs and AT owing to bat control. These
estimates are presented in Table 3.
Pre-exposure vaccination costs are the aggregated costs
associated with vaccinating all cattle in the endemic region
(rabies vaccine, syringe, cooler, ice and transportation
costs). Estimates of these costs were based on observed
prices in Mexico at the time the analysis was performed.
The government-sponsored vampire bat control program
cost was calculated on an annual basis and was based on
the authors’ knowledge of the costs’ smaller-scale bat
control efforts, which includes the salary of the capture
teams and expenditures on nets, traps and other items.
Individual costs associated with the cattle vaccination
program and bat control program are presented in Table 3.
Table 2 displays the formulas used to calculate the four
different benefit-cost ratios. For each, the equivalent net
benefit is the numerator minus the denominator.
The calculation of the various benefit-cost ratios is based
on twenty different variables. Because there is considerable
uncertainty about the true value of these variables, two
Monte Carlo simulations were performed to calculate the
appropriate benefit-cost ratios. These simulations differed
only in the degree of assumed uncertainty in the variables.
The estimates of V, PEP and AT are in the form of a range,
and it is assumed that these are uniformly distributed
across that range. For the remaining variables, an expected
value was estimated, but a range was not estimated. Given
the inherent uncertainty in these estimates, each Monte
Carlo simulation makes an arbitrary assumption about the
distribution around each of these expected values. Specifi-
cally, it is assumed that these remaining variables follow a
triangular distribution where the minimum and maximum
values are ±25% (25% Monte Carlo) and ±50% (50%
Monte Carlo) of the estimated expected value of that vari-
able.1 These alternative assumptions give an indication of
how different degrees of uncertainty in the variables will
affect the benefit-cost ratios. The specific assumptions
made for each variable are given in Table 3.
Table 2. Benefit-cost ratios (BCR)
Livestock vaccination only (rancher)
BCRvaccine; rancher ¼
V
100 ½PnðN M100Þ
PvQv þ PcQc þ PiQi þ Pf Qf
Livestock vaccination only (social)
BCRvaccine; social ¼
V
100 Pn N
M
100
  þ AT100 ðPatQatÞ
PvQv þ PcQc þ PiQi þ Pf Qf
Bat control only (social)
BCRbat control; social ¼
PEP
100 ðPpepQpepÞ
B
Combined (social)
BCRcombined; social ¼
V
100 Pn N
M
100
  þ PEP100 ðPpepQpepÞ þ AT100 ðPatQatÞ
PvQv þ PcQc þ PiQi þ Pf Qf þ B
1For symmetric triangular variables, the mode equals the expected value.
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Each simulation proceeded by randomly drawing values
for each of the variables based on the assumed distribution
and the parameter values of those distributions. The simu-
lations were performed in Microsoft Excel and the rand()
function was used to generate random numbers. This
made the draws of the uniform variables simple, but draws
from the triangular variables required an additional step.
Random draws from a triangular distribution were simu-
lated by generating a random number on the uniform
interval [0,1] using rand() and evaluating the inverse of the
triangular cumulative distribution function (Equation 1) at
that number.
Given the drawn values of the 20 variables, the appro-
priate benefit-cost ratios and net benefits were then calcu-
lated. This process was repeated 200 000 times to
sufficiently characterize the mean, median and variance or
the benefit-cost ratios.
Results
The mean, median and variance of the 200 000 iterations
in each simulation were calculated for the four different
benefit-cost ratios. The social net benefit of the full vampire
bat rabies management plan was also calculated (Table 4).
For all of the benefit-cost ratios and the net benefit, the
mean is larger than the median, implying that the distribu-
tions of these values are right-skewed. As expected, the vari-
ances of the results from the 50% Monte Carlo are
significantly larger than those for the 25% Monte Carlo.
An approximation of the probability density function was
also produced for the full program’s social benefit-cost ratio
(Graph 1), the vaccination component’s social benefit-cost
ratio (Graph 2), the vaccination component’s private bene-
fit-cost ratio (Graph 3) and the bat control component’s
social benefit-cost ratio (Graph 4). It can be seen that the
distributions are right-skewed. The distribution from the
25% Monte Carlo have more mass around their means and
medians, while the distributions from the 50% Monte Carlo
have thicker tails, indicating a higher probability that the
true benefit-cost ratio is relatively low or very high. Given
the assumptions made about the variables in both the 25%
and 50% Monte Carlo simulations, there is zero probability
that the combined program’s social benefit-cost ratio or the
vaccination program’s private and social benefit-cost ratios
are less than one. However, under the assumptions of the
25% Monte Carlo, the probability that social benefit-cost
ratio of the bat control program is greater than one is zero.
Under the assumptions of the 50%Monte Carlo, the proba-
bility of that same outcome is only 0.7%.
Discussion
A comprehensive program to control the impacts of vampire
bat rabies might include both a bat control component and
a livestock vaccination program. However, the results from
our analysis indicate that when judged purely by the metric
of economic efficiency, the vaccination component is a bet-
ter use of resources than the bat control program. The
expected social benefit-cost ratio of the vaccination compo-
nent is over six, indicated that for every peso spent on vacci-
nations, more than six pesos are realized in benefits. These
benefits arise from both reduced cattle mortality and less
need to test livestock for rabies. However, the private bene-
fit-cost ratio of the vaccination program is only very slightly
lower than the social ratio, implying the vast majority of
Table 3. Distribution and parameter assumptions
Variable
Distributions
Uniform: U(lower, upper)
Triangular: T(lower, mode, upper)
25% Monte Carlo 50% Monte Carlo
N T(10 235 238,
13 646 984,
17 058 730)
T(6823492,
13,646,984,
20,470,476)
M T(0.75, 1, 1.25) T(0.5, 1, 1.5)
Pv T(6.75, 9, 11.25) T(4.5, 9, 13.5)
Qv T(10 235 238, 13
646 984, 17 058 730)
T(6 823 492,
13 646 984, 20
470 476)
Pc T(45, 60, 75) T(3420, 6840, 10 260)
Qc T(810, 1080, 1350) T(540, 1080, 1620)
Pi T(15, 20, 25) T(10, 20, 30)
Qi T(4500, 6000, 7500) T(3000, 6000, 9000)
Pf T(6, 8, 10) T(4, 8, 12)
Qf T(180 000, 240 000,
300 000)
T(120 000,
240 000, 360 000)
Pn T(5130, 6840, 8550) T(3420, 6840, 10 260)
V U(75, 95) U(75, 95)
P T(1500) T(750, 1500, 2250)
Q T(716, 955, 1193) T(477, 955, 1432)
Pat T(90, 120, 150) T(60, 120, 180)
Qat T(213, 283, 354) T(142, 425, 283)
B T(1 492 823, 1990
430, 2 488 038)
T(995 215, 1990
430, 2 985 645)
PEP U(25, 75) U(25, 75)
AT U(75, 95) U(75, 95)
(1)F1ðyÞ ¼ Lþ
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
yðM  LÞðU  LÞp for 0\y\ðM  LÞ=ðU  LÞ
U  ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffið1 yÞðU MÞðU  LÞp for ðM  LÞ=ðU  LÞ\y\1

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Graph 1. Probability density function of social benefit-cost ratios of combined programs.
Table 4. Monte Carlo simulation results
Bat control
program BCR
Vaccine program
social BCR
Vaccine program
rancher BCR
Combined
social BCR
Combined social
NB (Mex$)
25% Monte Carlo
Mean 0.36 6.42 6.42 6.32 667 357 655
Median 0.35 6.31 6.31 6.22 656 284 026
Variance 0.02 1.50 1.50 1.44 2.11578E + 16
50% Monte Carlo
Mean 0.38 6.64 6.64 6.52 667 787 752
Median 0.34 6.24 6.24 6.14 629 490 213
Variance 0.03 6.31 6.31 6.01 7.89226E + 16
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Graph 2. Probability density function of social benefit-cost ratios of vaccination program.
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benefits provided by the vaccination program are realized by
cattle producers. If subsidation of any vaccination program
requires evidence of large social benefits beyond the benefits
that accrue to cattle producers, it appears little subsidation
could be justified, although the role of government assis-
tance should not be completely discounted.
Given the large private benefits associated with cattle vacci-
nation, it is curious that relatively few cattle are vaccinated.
Several factors that may explain this include lack of education
and awareness, as well as lack of access to the vaccine and vet-
erinary care. It therefore seems clear that if the government is
going to devote resources to a vaccination program, it can
best do so in a way that increases producers’ awareness of the
problem, which shows the benefits of vaccination and eases
access to the vaccine and veterinary care.
The results of the Monte Carlo simulation highlight the
degree to which uncertainty in the data leads to uncertainty
in the results. Given the assumptions of the two simulations
performed in this analysis, the ranges of possible outcomes
for all of the benefit-cost ratios are large. However, when
considering any benefit-cost ratio, the value of one is the rel-
evant threshold. Below this, costs outweigh benefits and the
conclusion is inefficiency. Above one, the action is efficient.
Our results indicate that the probability that the social or
private benefit-cost ratios for the vaccination program are
less than one is zero. It is thus reasonable to conclude that
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Graph 3. Probability density function of private benefit-cost ratios of vaccination program.
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the vaccination component of the program is efficient. How-
ever, our results also indicate that the probability of the bat
control component of the program producing a benefit-cost
ratio greater than one is very small. Thus, this part of the
program is likely inefficient. There is no need for these dif-
ferent components to be implemented together, and maxi-
mum efficiency is reached by implementing the vaccination
component but not the bat control component.
While the two Monte Carlo simulations show how an
assumed level of uncertainty leads to uncertainty in the
results, the true value of any of the variables may lie outside
the intervals assumed by even the 50%Monte Carlo. Assum-
ing larger amounts of uncertainty in the variables will lead to
a wider range of possible results. If enough uncertainty is
assumed into the variables, virtually any result becomes pos-
sible. However, at some point further increases in the possi-
ble ranges the variables can take becomes implausible, and
we believe the assumption we have made stop short of this
point while still highlighting the potential range of results.
Vampire bat rabies causes significant impacts within its
endemic region in Mexico. These impacts include livestock
mortality, animal testing costs, post-exposure prophylaxis
costs and human mortality risk. We evaluated the economic
efficiency of two methods of mitigating these impacts: live-
stock vaccination and bat control. While economic efficiency
is not the only way to judge the desirability of these methods,
it is an important consideration. Inefficiency implies that the
value of resources used by the method outweighs the benefits
provided. If, in fact, mitigating the impacts of vampire bat
rabies is economically efficient, such a finding deserves con-
sideration by both livestock producers and policymakers
within the affected region.
Our analysis indicates that a program of cattle vaccina-
tion is efficient, while a program of bat control is ineffi-
cient. Based on our assumptions, the probability that the
costs of vaccination outweigh the benefits is zero.
The expected benefits provided by vaccination are more
than six times the costs, even when considering the costs of
distributing the vaccines. Bat control, however, is highly
unlikely to be efficient given our assumptions. This results
from the high costs associated with the program, as well as
the uncertain benefits it provides.
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